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Background
Among the chemical class of coumarins several substances
have been described to be effective as cognition enhanc-
ers. We have recently characterized the coumarin scopole-
tin as a compound which fits a pharmacophore model of
AChE inhibitors and enhances the release of ACh in rat
brain [1]. Now, a comprehensive study was carried out in
order to investigate the effects of scopoletin on learning
and memory, on release of ACh from synaptosomes and
on hippocampal long-term potentiation (LTP) in order to
uncover the mechanism of action.
Materials and methods
Learning and memory: The effect of scopoletin on learning
and memory was tested on normal and scopolamine-
amnestic mice with the T-maze alternation and the object
recognition test. Release of ACh from synaptosomes of rat
brain frontal cortex: Synaptosomes were incubated with
[3H]choline and the release of the formed [3H]ACh from
superfused synaptosomes placed on filters was deter-
mined. The effect of scopoletin, galantamine and
mecamylamine on ACh release was investigated. Neural
transmission and neuroplasticity in hippocampus: Basal field
EPSPs (fEPSPs) and LTP-amplified fEPSPs were evoked in
the CA1 subfield of slices of rat hippocampus by stimula-
tion of the Schaffer collateral projection and the effects of
scopoletin, nicotine and mecamylamine on basal fEPSPs
and on LTP were studied.
Results
Scopoletin (20 μg; i.c.v.) abolished the scopolamine-
induced impairment on alternation in the T-maze and on
object recognition, while it was ineffective in normal
mice. Scopoletin enhanced the 15 mM K+-induced release
of ACh from synaptosomes, showing a bell-shaped dose-
effect curve (maximum effective concentration: 4 μM),
similar to that of galantamine (maximum effective con-
centration: 1 μM). The effect of both compounds was
blocked by the nAChR antagonist mecamylamine, show-
ing the involvement of nAChRs. In superfused slices from
rat hippocampus, scopoletin (4 μM) did not influence
basal fEPSPs but it amplified the LTP-induced increase of
the fEPSPs. The effect of scopoletin on neuronal plasticity
was abolished by mecamylamine. These properties of sco-
poletin were also found for the positive control com-
pound nicotine.
Conclusion
The effects of scopoletin on the performance of mice in
the learning tasks and on hippocampal LTP suggest that
this compound exerts cognition-enhancing properties.
The inhibition of LTP amplification and of presynaptic
synaptosomal ACh release by mecamylamine point to the
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involvement of nAChRs. Though previous studies found
AChE inhibitory (IC50: 168 μM) and weak MAO inhibi-
tory activity, the predominant mechanism of action might
be the nicotinic agonist property.
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